Symbol="ABEO"
AssetType="Common Stock"
Name="Abeona Therapeutics Inc"
Description="Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for rare, life-threatening genetic diseases. The company is headquartered in New York, New York."
CIK="318306"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1330 AVENUE OF THE AMERICAS, 33RD FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="82075000"
EBITDA="-42238000"
PERatio="None"
PEGRatio="0"
BookValue="0.435"
DividendPerShare="0"
DividendYield="0"
EPS="-2.21"
RevenuePerShareTTM="0.261"
ProfitMargin="0"
OperatingMarginTTM="-12.62"
ReturnOnAssetsTTM="-0.573"
ReturnOnEquityTTM="-2.672"
RevenueTTM="3568000"
GrossProfitTTM="-28001000"
DilutedEPSTTM="-2.21"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.5"
AnalystTargetPrice="21"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.71"
PriceToBookRatio="3.31"
EVToRevenue="9.47"
EVToEBITDA="-0.515"
Beta="1.346"
num_52WeekHigh="5.8"
num_52WeekLow="2.19"
num_50DayMovingAverage="3.898"
num_200DayMovingAverage="3.248"
SharesOutstanding="22062600"
DividendDate="None"
ExDividendDate="None"
symbol="ABEO"
open="3.62"
high="4.10"
low="3.54"
price="3.79"
volume="340356.00"
latest_trading_day="2023-08-18"
previous_close="3.54"
change="0.25"
change_percent="7.0621%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="9"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="91"
Volume_recent_avg="154796"
Change_recent_avg="0.01"
Delta_recent_avg="0.26"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="0.15"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="91"
Aroon_momentum_negative="9"
image_negative_thumbnail_id_1="120"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0056.jpeg"
image_negative_thumbnail_id_2="1118"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0151.jpeg"
image_neutral_thumbnail_id_1="558"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0041.jpeg"
image_neutral_thumbnail_id_2="576"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_positive_thumbnail_id_1="702"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0006.jpeg"
image_positive_thumbnail_id_2="610"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0098.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1179"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
